Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

Core Viewpoint - The main observation is that there was a net outflow of 974 million yuan in the main funds of the Shanghai and Shenzhen markets at the end of the trading day on December 22, with specific sectors showing significant inflows [1] Group 1: Market Overview - At the end of the trading day, the main funds in the Shanghai and Shenzhen markets experienced a net outflow of 974 million yuan [1] - The electric equipment, banking, and pharmaceutical industries saw net inflows exceeding 100 million yuan each [1] Group 2: Individual Stocks - Yangguang Electric experienced a net inflow of over 200 million yuan, leading the individual stock inflows [1] - Aerospace Development, Wolong Electric Drive, Tongyu Communication, Tianfu Communication, and Haiguang Information each had net inflows exceeding 100 million yuan [1]

本次增资扩股后，中洪通宇的注册资本由人民币20,000万元增加至人民币21,000万元，公司对中洪通宇 的持股比例由90%变更为85.7143%。中洪通宇仍为公司合并报表范围内子公司。 通宇通讯（002792）(002792.SZ)发布公告，为进一步增强公司控股子公司湖北中洪通宇空间技术有限 公司(以下简称"中洪通宇")的资本实力，根据公司战略规划和经营发展需要，中洪通宇拟以增资扩股形 式引入投资者武汉武创院投资有限公司(以下简称"武创院投资")。武创院投资拟以现金方式增资1,000万 元，增资金额全部计入注册资本。公司作为中洪通宇的现有股东，放弃本次增资的优先认缴出资权。 ...

智通财经APP讯，通宇通讯(002792.SZ)发布公告，为进一步增强公司控股子公司湖北中洪通宇空间技术 有限公司(以下简称"中洪通宇")的资本实力，根据公司战略规划和经营发展需要，中洪通宇拟以增资扩 股形式引入投资者武汉武创院投资有限公司(以下简称"武创院投资")。武创院投资拟以现金方式增资 1,000万元，增资金额全部计入注册资本。公司作为中洪通宇的现有股东，放弃本次增资的优先认缴出 资权。 本次增资扩股后，中洪通宇的注册资本由人民币20,000万元增加至人民币21,000万元，公司对中洪通宇 的持股比例由90%变更为85.7143%。中洪通宇仍为公司合并报表范围内子公司。 ...

格隆汇12月22日丨通宇通讯(002792.SZ)公布，为进一步增强广东通宇通讯股份有限公司控股子湖北中 洪通宇空间技术有限公司（简称"中洪通宇"）的资本实力，根据公司战略规划和经营发展需要，中洪通 宇拟以增资扩股形式引入投资者武汉武创院投资有限公司（简称"武创院投资"）。武创院投资拟以现金 方式增资1,000万元，增资金额全部计入注册资本。公司作为中洪通宇的现有股东，放弃本次增资的优 先认缴出资权。本次增资扩股后，中洪通宇的注册资本由人民币20,000万元增加至人民币21,000万元， 公司对中洪通宇的持股比例由90%变更为85.7143%。中洪通宇仍为公司合并报表范围内子公司。 ...

格隆汇12月22日｜通宇通讯(002792.SZ)公告称，公司控股子公司中洪通宇拟以增资扩股形式引入投资 者武汉武创院投资有限公司，后者拟以现金方式增资1000万元，增资金额全部计入注册资本。增资后， 中洪通宇注册资本由2亿元增加至2.1亿元，通宇通讯持股比例由90%变更为85.7143%。此次增资旨在增 强中洪通宇资本实力，满足其卫星通信产品研发及运营支出的资金需求。 ...

| 公告日期 2025-12-22 | 异常期间 | | | | | --- | --- | --- | --- | --- | | 通宇通讯 (002792) | 成交量 | 147,855,231 份/股 | 成交金额 | 5,028,065,628 元 | | 日价格涨幅偏离有达到8 87% | | | | | 通宇通讯今日涨停，成交额50.28亿元，换手率44.35%。盘后龙虎榜数据显示，深股通专用席位买入1.25亿元并卖出1.12亿元，有2家机构专用席位净卖出 1.20亿元。陈小群席位净买入9021万元。 | 买卖 | 会员营业部名称 | 买入金额 | 卖出金额 | | --- | --- | --- | --- | | | | (元) | (元) | | 买1 | 深股通专用 | 125,107,692 | 112,396,357 | | 买2 | 中国银河证券股份有限公司大连黄河路 证券营业部 | 90,523,255 | 304,797 | | 播3 | 华鑫证券有限责任公司深圳分公司 | 68,140,480 | 16,960 | | 买4 | 平安证券股份有限公司深圳分公司 | 67,72 ...

通宇通讯公告，为增强控股子公司中洪通宇资本实力，中洪通宇拟增资扩股引入投资者武创院投资，增 资金额1000万元，全部计入注册资本。增资后，中洪通宇注册资本由2亿元增至2.1亿元，通宇通讯持股 比例由90%变更为85.7143%。此次增资不构成关联交易或重大资产重组，不需提交董事会、股东会审 议。武创院投资与公司无关联关系或利益安排。增资款将用于中洪通宇主营业务及补充流动资金。 ...

Group 1 - F5G concept stocks rose by 3.15%, ranking 7th among concept sectors, with 32 stocks increasing in value, including notable gainers such as TeFa Information, Hengtong Optic, and Tongyu Communication, which hit the daily limit, with increases of 10.03%, 10.02%, and 9.99% respectively [1][2] - The top gainers in the F5G sector included Changxin Bochuang, which rose by 12.68%, and Huagong Technology, which increased by 6.37% [1][2] - The sector experienced a net inflow of 5.134 billion yuan, with 29 stocks receiving net inflows, and 9 stocks exceeding 100 million yuan in net inflows, led by Zhongji Xuchuang with 1.485 billion yuan [2][3] Group 2 - The net inflow ratios for leading stocks were significant, with TeFa Information at 39.28%, Hengtong Optic at 18.25%, and Chuangwei Digital at 13.31% [3][4] - The trading volume and turnover rates were notable, with Zhongji Xuchuang having a turnover rate of 3.57% and a trading volume of 148.541 million yuan [3][4] - Stocks such as Zhenyou Technology and Tiandi Technology faced declines of 4.66% and 0.52% respectively, indicating some volatility within the sector [5]

证券代码：002792 证券简称：通宇通讯 公告编号：2025-084 广东通宇通讯股份有限公司 关于控股子公司增资扩股引入投资者的公告 （7）经营范围：一般项目 : 信息系统集成服务；卫星通信服务；卫星导航 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本次增资事项概述 为进一步增强广东通宇通讯股份有限公司（以下简称"公司"或"通宇通讯"） 控股子湖北中洪通宇空间技术有限公司（以下简称"中洪通宇"）的资本实力， 根据公司战略规划和经营发展需要，中洪通宇拟以增资扩股形式引入投资者武汉 武创院投资有限公司（以下简称"武创院投资"）。武创院投资拟以现金方式增 资 1,000 万元，增资金额全部计入注册资本。公司作为中洪通宇的现有股东，放 弃本次增资的优先认缴出资权。本次增资扩股后，中洪通宇的注册资本由人民币 20,000 万元增加至人民币 21,000 万元，公司对中洪通宇的持股比例由 90%变更 为 85.7143%。中洪通宇仍为公司合并报表范围内子公司。 根据《深圳证券交易所股票上市规则》及《公司章程》等相关规定，本次增 资事项无需提交公司董事会、股东会 ...